Understanding the health impact of inactivity for the benefit of older adults and astronauts
A study using bedrest as an analog to microgravity will provide data for eight Canadian research projects
When is dead really dead?
Dr. Sam Shemie leads the death prediction and physiology after removal of therapy study (DePPaRT study)
RI-MUHC researchers support Canada’s efforts to address the COVID-19 pandemic
Drs. Emily McDonald and Todd C. Lee are part of the Canadian Network of COVID-19 Clinical Trials Networks...
Overcoming vaccine hesitancy
Our best hope of charting a course to a post-pandemic world
Early diagnosis is key to prevention of potentially fatal complication in type 1 diabetes
New RI-MUHC study of international data suggests awareness and access to care are key factors in improving...
New study of hydroxychloroquine usage may help personalize lupus treatment
RI-MUHC researchers identify factors associated with poor outcomes for lupus patients
Reaching new heights by working together: Innovative industry partnership
RI-MUHC-led team will use artificial intelligence to improve survival rates of cancer-diagnosed patients
Two studies confirm efficiency of saliva tests for COVID-19
Testing is the cornerstone of the fight against COVID-19, and a test that can be self-administered would greatly increase the options for case...
Saliva samples for COVID-19 testing: as good as nasopharyngeal swabs, but cheaper
New meta-analysis of 37 studies and over 7,000 paired saliva and nasopharyngeal swab samples
Could an antidepressant slow COVID-19 progression?
RI-MUHC researchers launch a clinical trial of fluvoxamine, a drug that has already proven efficient in reducing lung injury in animal studies and...
Clinical Innovation Platform at the RI-MUHC announces first member company
Health tech accelerator welcomes AltPAP Innovation to its new state-of-the-art facility
Could a different testing strategy reduce healthcare workers’ isolation after unprotected exposure to a confirmed case of COVID-19?
RI-MUHC study suggests appropriate...
Haply wins the CODE LiFE Ventilator Challenge
What’s next? “Gather the resources to bring the Haply device to millions around the world,” says Reza Farivar
Researchers identify the origin of a deadly brain cancer
Finding could lead to potential therapies
The RI-MUHC leads new clinical trial of COVID-19 treatment for hospitalized patients
Phase 2 study tests LAU-7b, a Canadian drug with dual antiviral and inflammation-controlling effects
RI-MUHC veterinarians engage in global effort to understand SARS-Cov-2
ARD platform members take centre stage at the 2020 Quebec Veterinary Congress
RI-MUHC researcher Nitika Pant Pai advocates improved access to HIV self-testing for Canadians
Canada approves HIV self-testing kit ahead of World AIDS Day 2020
Driving Personalized Medicine: The 2020 RI-MUHC Annual Report is online!
An invitation from Dr. Miguel Burnier Jr.
RI-MUHC team identifies new gene associated with risk of cardiovascular diseases
New study analyses millions of genetic variants in almost 300,000 individuals
New services for cancer patients at the RI-MUHC Centre for Innovative Medicine
The Centre for Innovative Medicine and Cedars Cancer Centre jointly offer additional space for infusion treatments